神经生物技术的创新策略,通过治疗性微藻和宏藻潜力,针对阿尔茨海默病
Merna Wagdy1, Abeer A Ibrahim1, Alaa M Yahia1
1Botany Department, Faculty of Science, Mansoura University, Mansoura 35516, Egypt..
Journal of neuroimmunology
|December 3, 2025
概括
海洋藻提供具有抗氧化和抗炎性能的天然化合物,对阿尔茨海默病 (AD) 治疗有希望. 将这些藻类疗法与CRISPR-Cas9基因编辑相结合,可以提供针对AD的新型神经保护策略.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 海洋生物技术 海洋生物技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,影响全球数百万人,其特点是认知能力下降.
- 目前的AD治疗方法具有有限的疗效和潜在的副作用.
- 来自藻类的天然疗法由于其抗氧化和抗炎性质,是有前途的替代品.
研究的目的:
- 探索藻类化合物和基因编辑技术在阿尔茨海默病治疗中的协同潜力.
- 为新的治疗策略建立神经生物技术和海洋生物资源的桥梁.
主要方法:
- 关于藻类生物活性化合物及其对AD病理学影响的科学文献的综述.
- 在神经退行性疾病研究中检查CRISPR-Cas9基因编辑应用.
- 整合了来自分子生物学,药理学和基因组学的见解.
主要成果:
- 藻类化合物 (来自像Chlorella,Spirulina这样的微藻和像Fucus,Ecklonia cava这样的宏藻) 具有对AD有益的抗氧化和抗炎性质.
- 这些化合物显示出减轻AD特征的潜力,例如氧化应激和神经炎症.
- 通过向与疾病相关的基因,CRISPR-Cas9技术提供了更高的疗效.
结论:
- 藻类衍生的化合物具有重要的神经保护潜力,用于AD的预防和治疗.
- 藻类疗法和基因编辑的结合为对抗阿尔茨海默病提供了一种全新的多学科方法.
- 进一步的研究将海洋生物资源和先进的生物技术整合起来,这是治疗创新的必要条件.
相关概念视频
01:22Alzheimer's Disease: Treatment
764
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
764
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:21Green Algae
679
Green algae, also referred to as chlorophytes, are different from red algae in having the chloroplasts containing chlorophylls a and b, which give them their distinct green hue. However, they lack phycobiliproteins, preventing them from developing the red or blue-green pigmentation seen in red algae. In terms of photosynthetic pigment composition, green algae closely resemble plants and share a close evolutionary relationship with them. Taxonomically Green algae belong to Phylum Chlorophyta in...
679
01:28Overview of Algae
662
The kingdom Archaeplastida encompasses red and green algae, along with land plants. Unlike other protists with chloroplasts that arose through secondary endosymbiosis, only red and green algae originated from primary endosymbiotic events. This diverse group of eukaryotic organisms contains chlorophyll and performs oxygenic photosynthesis.Algae exist in various forms, from large brown kelp in coastal waters to green scum in puddles and stains on rocks or soil. Some species are responsible for...
662
01:19Other Algae
378
The group Stramenopiles include some phototrophic microorganisms. Members of this group possess flagella covered in numerous short, hairlike extensions, a feature that inspired the group's name, derived from the Latin words for "straw" and "hair." Some of the main categories of Stramenopiles include diatoms, golden algae, and brown algae.Diatoms are unicellular, photosynthetic eukaryotes, with over 200 known genera. They play a key role in the planktonic communities of both marine and...
378